Hormone sensitive advanced breast cancer
Common Questions and Answers about Hormone sensitive advanced breast cancer
hormone
Hi,
How are you? There are many options for breast cancer treatment and several factors such as type of breast cancer, its stage, whether the cancer cells are sensitive to hormones, patient's overall health and medical condition that needs to be considered. After diagnosis, most women undergo surgery for breast cancer and receive additional treatment, such as chemotherapy, hormone therapy or radiation. Aggressive and early treatment usually results to remission. Take care and best regards.
Lobular breast cancer accounts for about 10 percent of invasive breast cancer -- the kind that threatens to spread -- according to the American Cancer Society. It can be treated with hormone-based therapies such as tamoxifen, but the tumors are more difficult to detect by mammograms, meaning it is often diagnosed in more advanced stages.
As you may know there is no permanent cure for advanced prostate cancer (yet). Radiation will slow down progression as will hormone therapy and chemo but none will cure advanced prostate cancer.
To maximize my chances I have had hormone therapy (Lupron & Casodex for 6 mos) combined with radiation therapy (38x IMRT sessions at 180 units/day) and will start chemo therapy (75 mg Taxotare, 8x sessions, 3 weeks apart) in about 2 weeks.
NEW YORK (Reuters Health) - After approximately 8 years, postmenopausal women with hormone-sensitive breast cancer who received (Arimidex), generically known as anastrazole, had a lower risk of recurrence than women taking tamoxifen, investigators reported at the annual meeting of the San Antonio Breast Cancer Symposium.
After an average of 68 months, women on Arimidex had a 15-percent greater disease-free survival and a 25-percent longer time to disease recurrence than women on tamoxifen.
Having a positive HER-2NEU implies a more aggressive type of breast cancer. HER-2 positivity also implies that your tumor is sensitive to some of the new cancer drugs like Herceptin. Being HER-2 negative means that you would not benefit from Herceptin use.
The Premarin (conjugated estrogen tablets) you were taking did not cause your breast cancer, but could have provided an added stimulus for the growth of your cancer.
Is there a link between breast lumps,cysts, cancer due to hormone imbalance since it showed up so soon after my hysterectomy. I do have fibrocysts. Also, is there a program I could get some assistance to get an ultrasound to have it checked out even though there doesn't seem to be anything there anymore.
Hi, I went to my GYN two yrs ago and she told me I have very lumpy breasts after doing a breast exam. She sent me for a mammo/ultrasound. The mammo came back clear but the ultrasound showed a cyst. They never told me at the time, anyway for two weeks now I have had breast soreness and strikes of pain (became slight burning) in my right breast so I went back to GYN.
First of all, I would like to clarify that the FEC regimen is commonly used not only when breast cancer is confined to the breast and nearby lymph nodes, but also when it has spread to other vital organs like the liver, lungs, or bone. However, saying that FEC is useful in treating metastatic or Stage 4 disease does not automatically make it the appropriate choice for your mother's case.
Hello,
Yam is supposed to be used for vaginal dryness but Hormone-sensitive condition such as breast cancer, uterine cancer, ovarian cancer, endometriosis, or uterine fibroids may become aggravated by using this herbal drug and hence you should not use it without medical guidance.
It is very difficult to precisely confirm a diagnosis without examination and investigations and the answer is based on the medical information provided. For exact diagnosis, you are requested to consult your doctor.
, locoregional or distant recurrence or contralateral breast cancer), postmenopausal women with hormone receptor–positive breast cancer should consider an AI, either as primary adjuvant therapy for 5 years or sequentially after 2 to 3 years of tamoxifen to yield a total of 5 years of adjuvant endocrine therapy. Women who discontinue initial AI therapy before 5 years should consider using tamoxifen to bring the total duration of adjuvant therapy to 5 years.
Pathologists use several techniques to test hormone receptors on tissue, and determine if the breast cancer cells respond, or attach, to E and P. Breast cancer is termed ER (or PR)-positive if its cells have more than a pre-specified baseline “cutoff” level of hormone receptors - the more a breast cancer responds, the higher its numerical test score. So 100% positive would indicate that in this specimen 100% of the cells have hormone receptors.
Recommended
